Literature DB >> 10958114

The neurosteroid pregnanolone prevents the anxiogenic-like effect of inescapable shock in the rat.

D Bitran1, D A Klibansky, G A Martin.   

Abstract

RATIONALE AND
OBJECTIVES: The ability of progesterone (P4) and its neurosteroid metabolite, 3alpha-OH-5beta-pregnan-20-one (pregnanolone) in protecting against the anxiogenic-like effect of inescapable shock (IS) in male rats was examined, as these steroids exert anxiolytic, anticonvulsant, and ataxic effects similar to the benzodiazepines (BZ), drugs shown to prevent IS-induced anxiogenesis.
METHODS: Adult male rats were injected with pregnanolone (8 mg/kg, SC), P4 (4 mg/rat) or its appropriate vehicle before exposure to IS. Twenty-four hours later, animals were injected with the steroid or its vehicle and then tested in the elevated plus-maze. In a control experiment, animals were injected with chlordiazepoxide (CDP, 15 mg/kg, IP) or vehicle before IS, and tested in the plus-maze 24 h later.
RESULTS: Whereas CDP or pregnanolone before IS resulted in the loss of the anxiogenic-like response seen 24 h after IS, P4 before IS did not protect against the anxiogenic-like effect of IS. The acute anxiolytic-like effect of pregnanolone and P4 was lost in animals that were injected with vehicle before the IS, but was observed in animals that were injected with the steroids before IS. Moreover, P4 injection in non-shocked animals was associated with an anxiogenic-like response observed 24 h after steroid administration.
CONCLUSION: The protection against the effect of IS afforded by a GABAergic neurosteroid is comparable to that observed with BZs, and thus provides further evidence of an allosteric relationship between the neurosteroid and BZ binding site on the GABA(A) receptor complex.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10958114     DOI: 10.1007/s002130000472

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  8 in total

1.  Neurosteroids and self-reported pain in veterans who served in the U.S. Military after September 11, 2001.

Authors:  Jason D Kilts; Larry A Tupler; Francis J Keefe; Victoria M Payne; Robert M Hamer; Jennifer C Naylor; Rohana P Calnaido; Rajendra A Morey; Jennifer L Strauss; Gillian Parke; Mark W Massing; Nagy A Youssef; Lawrence J Shampine; Christine E Marx
Journal:  Pain Med       Date:  2010-08-23       Impact factor: 3.750

2.  Low doses of cocaine decrease, and high doses increase, anxiety-like behavior and brain progestogen levels among intact rats.

Authors:  Amy S Kohtz; Jason J Paris; Cheryl A Frye
Journal:  Horm Behav       Date:  2010-02-19       Impact factor: 3.587

3.  Cortical 3 alpha-hydroxy-5 alpha-pregnan-20-one levels after acute administration of Delta 9-tetrahydrocannabinol, cocaine and morphine.

Authors:  A Chistina Grobin; Margaret J VanDoren; Linda J Porrino; A Leslie Morrow
Journal:  Psychopharmacology (Berl)       Date:  2004-12-24       Impact factor: 4.530

4.  When Adaptations Go Awry: Functional and Dysfunctional Aspects of Social Anxiety.

Authors:  Jon K Maner; Douglas T Kenrick
Journal:  Soc Issues Policy Rev       Date:  2010-12

5.  Histories of major depression and premenstrual dysphoric disorder: Evidence for phenotypic differences.

Authors:  Rebecca R Klatzkin; Monica E Lindgren; Catherine A Forneris; Susan S Girdler
Journal:  Biol Psychol       Date:  2010-02-04       Impact factor: 3.251

6.  Anxiolytic-like property of risperidone and olanzapine as examined in multiple measures of fear in rats.

Authors:  Tao Sun; Wei He; Gang Hu; Ming Li
Journal:  Pharmacol Biochem Behav       Date:  2010-02-16       Impact factor: 3.533

Review 7.  Neurosteroids in the context of stress: implications for depressive disorders.

Authors:  Susan S Girdler; Rebecca Klatzkin
Journal:  Pharmacol Ther       Date:  2007-05-24       Impact factor: 12.310

8.  Clozapine and olanzapine exhibit an intrinsic anxiolytic property in two conditioned fear paradigms: contrast with haloperidol and chlordiazepoxide.

Authors:  Alexa Mead; Ming Li; Shitij Kapur
Journal:  Pharmacol Biochem Behav       Date:  2008-10       Impact factor: 3.533

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.